Sympathetic hyperactivity in chronic kidney disease
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
There is clear evidence that chronic kidney disease (CKD) is often characterized by the presence of sympathetic hyperactivity. Importantly, data are accumulating that this sympathetic hyperactivity is indeed important, because it may influence cardiovascular and renal prognosis. Comprehensive reviews have been published elsewhere [1,2]. The purpose of this Editorial Comment is to briefly summarize available knowledge on the pathogenesis of sympathetic hyperactivity and to discuss its clinical relevance, the consequences of this knowledge for the choice of treatment and as yet unresolved issues. Already in the 1970s, increased catecholamine levels, as an index for sympathetic activity, were reported in CKD patients. With the microneurographic technique, true sympathetic nerve activity can be measured, usually as muscle sympathetic nerve activity (MSNA). This MSNA, for instance measured in the peroneal nerve, represents the centrally generated sympathetic nerve activity directed to resistance vasculature. Sympathetic activity is not uniform in all parts of the body. Therefore, techniques have been developed to assess sympathetic activity of a specific organ, for instance by measuring noradrenaline spillover (using tracer-labelled noradrenaline) or by imaging using 123I-metaiodobenzylguanidine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132 · cited 2×
“However, bilaterally nephrectomized patients have MSNA identical to healthy controls, indicating that the signal that commands the brain to increase sympathetic outflow is generated in the diseased kidneys [3].”
BackgroundZoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., et al. (2002) · Circulation · doi:10.1161/hc1102.105261 · Cited by 519 · cited 1×
“Plasma noradrenaline was an independent predictor for all-cause mortality and cardiovascular event in haemodialysis patients without overt heart failure [19].”
BackgroundSympathetic Activation in the Pathogenesis of Hypertension and Progression of Organ Damage
Mancia, G., Grassi, G., Giannattasio, C., & Seravalle, G. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.724 · Cited by 471 · cited 1×
“Sympathetic activity contributes to the development of other forms of organ damage independent of its effect on blood pressure [18].”
BackgroundSympathetic Nerve Activity Is Inappropriately Increased in Chronic Renal Disease
Klein, I. H. H. T., Ligtenberg, G., Neumann, J., Oey, P. L., Koomans, H. A., & Blankestijn, P. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000098687.01005.a5 · Cited by 167
Self-citationSTROJEK, K., GRZESZCZAK, W., GÓRSKA, J., LESCHINGER, M. I., & RITZ, E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v123602 · Cited by 112
Moxonidine treatment of hypertensive patients with advanced renal failure
Vonend, O., Marsalek, P., Russ, H., Wulkow, R., Oberhauser, V., & Rump, L. C. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00021 · Cited by 91 · cited 1×
“In a recent study from Germany, >90% of a CKD population was on an ACE inhibitor or an AngII-receptor antagonist [39].”
Background
Cited by
Function of Renal Nerves in Kidney Physiology and Pathophysiology
Osborn, J. W., Tyshynsky, R., & Vulchanova, L. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-091656 · Cited by 171
Renal Nerves and Long‐Term Control of Arterial Pressure
Osborn, J. W., & Foss, J. D. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c150047 · Cited by 93
“Another approach to determine the zero signal, since renal nerves are all postganglionic axons at the site of recording, is to administer a ganglionic blocking agent, such as hexamethonium, which inhibits all postganglionic sympathetic nerve activity (SNA).”
InfluentialDi Daniele, N., De Francesco, M., Violo, L., Spinelli, A., & Simonetti, G. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs044 · Cited by 49
Scalise, F., Sole, A., Singh, G., Sorropago, A., Sorropago, G., Ballabeni, C., Maccario, M., Vettoretti, S., Grassi, G., & Mancia, G. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002358 · Cited by 42
Metadata
- Authors
- Blankestijn, P. J.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04-06
- Volume
- 19
- Issue
- 6
- Pages
- 1354-1357
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2107524685
- Cited by
- 58
- References
- 6
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sympathetic hyperactivity in chronic kidney disease. https://app.cochat.ai/papers/10.1093/ndt/gfh242
- The paper
- Blankestijn, P. J. (2004). Sympathetic hyperactivity in chronic kidney disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfh242
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.